홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Triethylamine → 1-(3-[2-[4-(2,4-Dioxothiazolidin-5-ylmethyl)phenoxymethyl]-1-methyl-1H-benzimidazol-6-yloxy]phenyl)-3-[4-(trifluoromethyl)benzyl]urea

HRID 412346
인쇄

반응식

HRID 412346 반응식
[C:1](N1C=CN=C1)(N1C=CN=C1)=[O:2].[F:13][C:14]([F:24])([F:23])[C:15]1[CH:22]=[CH:21][C:18]([CH2:19][NH2:20])=[CH:17][CH:16]=1.Cl.Cl.[NH2:27][C:28]1[CH:29]=[C:30]([CH:58]=[CH:59][CH:60]=1)[O:31][C:32]1[CH:33]=[CH:34][C:35]2[N:39]=[C:38]([CH2:40][O:41][C:42]3[CH:55]=[CH:54][C:45]([CH2:46][CH:47]4[S:51][C:50](=[O:52])[NH:49][C:48]4=[O:53])=[CH:44][CH:43]=3)[N:37]([CH3:56])[C:36]=2[CH:57]=1.C(N(CC)CC)C>CN(C)C=O>[O:52]=[C:50]1[NH:49][C:48](=[O:53])[CH:47]([CH2:46][C:45]2[CH:54]=[CH:55][C:42]([O:41][CH2:40][C:38]3[N:37]([CH3:56])[C:36]4[CH:57]=[C:32]([O:31][C:30]5[CH:29]=[C:28]([NH:27][C:1]([NH:20][CH2:19][C:18]6[CH:21]=[CH:22][C:15]([C:14]([F:23])([F:24])[F:13])=[CH:16][CH:17]=6)=[O:2])[CH:60]=[CH:59][CH:58]=5)[CH:33]=[CH:34][C:35]=4[N:39]=3)=[CH:43][CH:44]=2)[S:51]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 8471TriethylamineHCID 682631,1'-CarbonyldiimidazoleHCID 768044-(Trifluoromethyl)benzylamineHCID 865877725-[4-[6-(3-aminophenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy]benzyl]thiazolidine-2,4-dione dihydrochloride

생성물 1

HCID 101226081-(3-[2-[4-(2,4-Dioxothiazolidin-5-ylmethyl)phenoxymethyl]-1-methyl-1H-benzimidazol-6-yloxy]phenyl)-3-[4-(trifluoromethyl)benzyl]urea
수율 20.7%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

To a solution of 1,1′-carbonyldiimidazole (130 mg) in anhydrous N,N-dimethylformamide (8 ml) was added 4-(trifluoromethyl)benzylamine (135 mg) and the mixture was stirred at room temperature for 2 hours. To the reaction mixture was added 5-[4-[6-(3-aminophenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy]benzyl]thiazolidine-2,4-dione dihydrochloride (400 mg) and triethylamine (153 mg) and the mixture was stirred at 60° C. for 1 hour and then allowed to stand at room temperature overnight. The reaction mixture was concentrated and partitioned between ethyl acetate and water. The extract was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate and then concentrated. The residue was chromatographed on a silica gel column using ethyl acetate as the eluant. The product insoluble in methanol was isolated by filtration and further purified by preparative reverse phase high performance liquid chromatography using acetonitrile:water=50:50→60:40 as the eluant to afford the title compound (102 mg, mp 127.9-132.4° C.).

후처리

  1. stirringthe mixture was stirred at 60° C. for 1 hour
  2. waitto stand at room temperature overnight
  3. concentrationThe reaction mixture was concentrated
  4. custompartitioned between ethyl acetate and water
  5. washThe extract was washed with saturated aqueous sodium chloride solution
  6. dry with materialdried over anhydrous sodium sulfate
  7. concentrationconcentrated
  8. customThe residue was chromatographed on a silica gel column
  9. customThe product insoluble in methanol was isolated by filtration
  10. customfurther purified by preparative reverse phase high performance liquid chromatography

출처 및 근거

ORD 기록
ord-26a6fd56b7ae42058f128adcb6b6fab7
출처 데이터셋
uspto-grants-2003_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06562849B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트